Individual Stocks VS Index Funds in 2019
2019 does not bode well for Stock
Indexes and therefore, Index funds. Buying Index funds has been the
go-to investment of individual investors (and some institutional
investors) for years now. Since 2009, many have done very well with
this simple strategy which has outdone many money managers over that
time.
2019 may be different for a number of
reasons! This bull market we have enjoyed since 2009, is getting very
long in the tooth and 2019 is beginning to look like the end is in
sight.
The macro picture is a mishmash of poor
decisions and poor leadership from Central Banks and world leaders
alike. The news is dominated by trade war talks, Walls, Brexit, German
(read Euro) downturn, and Debt, beyond anything we have witnessed in the
past. Real war cannot be dismissed either as the USA and North Korea
are at a stalemate, and (nuclear armed) India and Pakistan are shooting
down each others fighter jets, to the cheers of their domestic
audiences.
With Britain on the verge of a "no deal"
Brexit, Italy may be becoming a financial basket case, German output is
inching into negative territory, and in France, the Macron government
has done nothing to right that ship.
Some believe that, Deutsche Bank may
well be the "Lehman Brothers" of the Euro zone this year as creditors
close in and a bailout partner is not in sight. The two largest
economies on the planet, USA and China are at serious odds over trade
AND both are in serious DEBT!
As the USA begins to withdraw from the
world under this administration, it owes $22 Trillion dollars and that
debt is now growing at 1.5 Trillion per year under Trump.
There are two ways to handle such a debt burden, 1: Default
2: reduce the dollar to a nickel. There
is no other way to pay down such a massive debt! (my bet is that, if it
were entirely up to Mr. Trump, he would pick door number 1)
There are now more refugees on the move
across the world than WW2 and most countries are putting up barriers to
entry. Euro zone countries from Spain to Greece are doing whatever they
can to keep out refugees, instead of welcoming them. Climate change,
inept governments and wars are the reasons for such a migration.
Witness the debacle in the USA on the
southern border as this president continues to threaten to shut down
government if he does not get his wall. This argument is a hideous
sidelight to what is truly going on in the world. This same
administration seems to admire despots while scorning democracy, whether
it is in it's own constitution or that of valuable allies.
The USA has now walked away from trade
agreements, peace treaties and most recently, a nuclear arms agreement
with Russia. None of these things bode well for markets, or indeed,
humanity, going forward, but the pied Pipers of Wall Street keep on
playing!
On a lesser, and personal financial
note, while most index funds have very low fees, they are paid annually,
and therefore, add up over time, eating into profits. As the value of
your investments go up, so do your fees. This is a built in strategy
that will eventually eat away at your gains. If these investments go
down, the fund still gets paid, every year!
Conversely, Buying individual stocks is
now usually done online for less than $10 per trade! (One time). When an
index tumbles, not all stocks are included. Some stocks actually go up
at such times.
The drawback:
Now you have to do homework! Stocks
are not index funds! They require you to do some investigating of your
own, unless, of course, you want to keep all your money in cash, gold
and silver, and buried in your back yard!
Monday, March 4, 2019
Monday, February 18, 2019
Investing in Domain names has been quite lucrative for many investors!
Why Invest In Domain Names?
- Domains are the real estate of the world wide web. Like other real estate assets, location is a big deal. The best location for a web address is, far and away, the .com domain!
- To this date, the .com extension has been the most sought after extension, followed by .net and .org however in the past several years many other extensions have come online, and some have found six and seven figure values, especially individual country domains.
- Now there are numerous extensions with words like ,fund, .money, .sex, .store, well, you get the picture!
Investments in web domain names has grown and there seems to be no end in sight for this rush to own a piece of the Web! - In early 2019, the Web Address Fund .com sold (for a second time) for an estimated value of 2.5 million dollars. The domainName, Retire .Com fetched $2 Million when sold several years ago. The value is not only found in the easy marketing of such addresses, but also in the fact that each of those terms are valuable search terms showing up on major search engines like Google and Yahoo millions of times, and, unbeknown to the mass public, the .com is the "default" address for all searches.
- It
makes sense to own valuable search terms and a domain that is easily
marketed and understood. To that end, we are offering these three
domains as a package, if the asking price is reached.
These 3 Retire Fund Domains on sale NOW
as a package!
RetireFund.com
RetireFund.net
RetireFund.org
3 premium web addresses for 1 price!
See: RETIREFUND.com now to buy or place a bid!
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
More Domains on Auction Here!
Neo Lithium's 3Q project is one of the purest, and largest Li projects in the world today!
There are MicroCaps and then there are:
"MicroCaps"!
Neo Lithium's 3Q project has the lowest impurities of "any" Lithium Brine project in the world, and is the 8th largest in size!
Company Highlights
- One of the highest-grade lithium brine assets in the world combined with the lowest critical impurity content of any known salar making it ideal for well-known and simple evaporation processing
- 8th largest lithium deposit in the world today!
- 100% ownership - The only Lithium company that owns an entire salar of this size without competitors or third parties
- Fully permitted to feasibility- EIA well advanced and expected to be finalized in Q1/Q2 2019
- Strong cash position and robust shareholder register
Experienced board and management focused on the Lithium sector.
CEO, Waldo Perez, was the original founder and past CEO of Lithium Americas.Chairman, Constantine Karayannopoulos was the director of Lithium Americas and an original founder of Neo Materials, now Molycorp.
Board and management members have strong experience in business development and capital markets.
Right
in the heart of the Lithium Triangle, the 3Q Project is located in
Catamarca Province, Argentina the largest lithium producing and
mining-friendly province in Argentina. Neo is situated between the truly bid dogs of Lithium production!
The 3Q Project has one
of the highest-grade lithium brine projects in the world, with a large
salar and lithium brine lake covering more than 150km2 and the Company
controls more 350km2 in and around the complex. The 3Q Project is 100%
owned by Neo Lithium.
The Company has obtained
environmental permitting to complete exploration and the pilot plant
and has also obtained the easement agreement to access the project for
future construction at the project site.
Update: As of this writing, Feb 18th 2019, the Pilot plant is delivered and is being put in place at 3Q!
We believe Neo Lithium is a prime takeover target in 2019
Disclosure: We own Shares in Neo Lithium!
Question: Do you?
Saturday, February 9, 2019
The first technological advance in the detection of atherosclerosis, heart disease and stroke in over 100 years awaiting FDA approval!
(ED Note: We first posted this article 11 months ago, and feel it is even more relevant now with FDA Approval pending)
Lexington Bio Sciences (LexingtonBioSciences.com)
Heart Disease and Heart Attacks are the number one killer of North Americans, and most people, worldwide. Nearly 1 in 3 deaths in the USA alone are attributed to Heart Attack and Stroke!
For 50% of these people, their "first" indication of a problem is a massive heart attack. They have no warning whatsoever.
Though taking blood pressure and heart
rates coupled with ultrasound techniques will sometimes indicate a
problem, the fact remains that, only in 50% of all cases do these
indicators work. Now, wouldn't it be great if there was a "Non-invasive"
way of determining, with a lot more accuracy, if heart disease is
prevalent in a patient, "before" the onset of a heart attack? Hey,
wouldn't it be great if that test was no more bother than simply taking
your blood pressure is?
Well, now there is such a device, currently in Clinical Trials, after 15 years of research and development in California Universities. Lexington BioSciences "HeartSentry" can measure something that has never been measured properly before. Endothelium
Endothelium, are the cells that line all arteries and are critical to the prevention of atherosclerosis, heart disease and stroke, the two leading causes of deaths worldwide (17.5 million people every year).
The significant value of measuring endothelial function is supported by many peer-reviewed studies.
For ease of use this new, life saving technology has been incorporated into a simple blood pressure cuff. Utilizing both blue tooth and cloud technology, the device to provide up-to-date, accurate readings of a patients complete cardiovascular health via electronic monitoring.
As you might expect, this is a significant development in a multi-billion dollar market, and all the patents and the technology are owned by a MicroCap Business, owned and operated by PHD's
Well, now there is such a device, currently in Clinical Trials, after 15 years of research and development in California Universities. Lexington BioSciences "HeartSentry" can measure something that has never been measured properly before. Endothelium
Endothelium, are the cells that line all arteries and are critical to the prevention of atherosclerosis, heart disease and stroke, the two leading causes of deaths worldwide (17.5 million people every year).
The significant value of measuring endothelial function is supported by many peer-reviewed studies.
For ease of use this new, life saving technology has been incorporated into a simple blood pressure cuff. Utilizing both blue tooth and cloud technology, the device to provide up-to-date, accurate readings of a patients complete cardiovascular health via electronic monitoring.
As you might expect, this is a significant development in a multi-billion dollar market, and all the patents and the technology are owned by a MicroCap Business, owned and operated by PHD's
Friday, August 10, 2018
As Crypto Currencies rise and begin to dominate investors thinking, Crypto Domain names are gaining popularity!
Whether you agree or disagree that Digital Assets like Crypto Currencies have value, you cannot escape the facts!
9 years ago Bitcoin was selling under $1 Dollar.
Today, (ups and downs aside) it sells around $6400!
That, my friends is an extreme jump in an investment!
As all Cryptos have increased
in price (for instance Ethereum Classic is up from a few cents to $14) Investors everywhere are wondering how they can get an edge in this new form of investing.
And, as more and more Banks and Businesses increase their Blockchain knowledge (and hire Crypto and Blockchain experts) to investigate how they can more securely transfer money and accounts worldwide, there is another avenue of Crypto investments that may have escaped the attention of mainstream investors.
That is the area of Crypto Domain names (Web Addresses)
Namepros.com lists the top ten CryptoDomains sold Here to date!
As you can see, the domain Eth.Com lead the pack at a cool $2,000,000
As you can also see in that list, many other Crypto domains like CryptoWorld and CryptoBank sold in 6 figures!
Even the lesser Dot com domains sold in 5 figures.
Domainers have been scooping up these domains by the hundreds, because they know that the new Crypto business startups will be looking for online addresses and possibly new branding.
So, Are DomainNames.Money?
You Bet they are!!!
Monday, July 30, 2018
About Lexington Bio Sciences - Early Detection and prevention of Heart Disease and Stroke!
|
|
|
|
More From Lexington BioSciences
Lexington BioSciences Inc. aims to become a leader in the development of cardiovascular measurement solutions proposed for common clinical applications with the potential for future home use.
Please visit our website to watch our video, find out more about us, and subscribe to Twitter or Facebook to receive the latest news, newsletters, blog posts and more.
Join the conversation about our exciting HeartSentry product
Join the conversation about our exciting HeartSentry product
|
Thursday, November 17, 2016
Subscribe to:
Posts (Atom)